Corporate
News Releases
2026
March
Pharmaceuticals
Otsuka Pharmaceutical to Acquire Transcend Therapeutics - Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend’s portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD) -
Pharmaceuticals
Otsuka Submits Application in Japan for Iclusig® for First-Line Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Pharmaceuticals
Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting
Pharmaceuticals
Launch of Joint Sales of the QuickNavi™-Campylobacter Antigen Diagnostic Kit in Japan
Nutraceuticals
New and Improved Calorie Mate JELLYEnhanced Taste and Balanced Nutrition, Now Even More Accessible
Corporate
Otsuka Pharmaceutical Appointments of Board Members and Statutory Auditors (PDF: 148.8 KB)
Corporate
Otsuka Pharmaceutical Named Tokyo Sports Promotion Model Company (Sports Practice Category) Employee and Communities Health Initiatives Recognized
Nutraceuticals
New Release: SOYJOY Azuki & HojichaA Deep Japanese Flavor with Gentle Sweetness and a Roasted Aroma
Pharmaceuticals
Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension,Now Covered by Insurance and Commercially Available in Japan
February
Nutraceuticals
New Product Release: /zeroz - a self-conditioning food that supports the body's natural abilities and contains plant-derived kaempferol to help make more effective use of oxygen
Nutraceuticals
Otsuka to Sponsor TOKYO MARATHON 2026Supporting Runners from Around the World Under the Theme "Believe in People's Potential."
Pharmaceuticals
REXULTI ® Listed in the "Essential Medicines List for the Ultra-Acute Phase of Disasters" by the Japanese Association for Disaster Medicine
Pharmaceuticals
Opening Egypt's First ORONAMIN C DRINK FactoryMeeting Growing Demand and Contributing to Community Health
Pharmaceuticals
Otsuka Enters into Agreement with South Korea-based Sky Labs for Exclusive Commercialization Rights in Japan to the Automated Blood Pressure Monitor CART BP pro First-in-world ring‑type blood pressure monitor that has received regulatory approval and insurance reimbursement in South Korea
Nutraceuticals
Tianjin Otsuka Beverage Opens New POCARI SWEAT Factory New facility to serve as a "health awareness hub"
January
Pharmaceuticals
Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults
Nutraceuticals
Otsuka Pharmaceutical Begins Rollout of PET Bottles Made from 100% Recycled PET ResinAiming to Realize a Decarbonized and Circular Society
Pharmaceuticals
Otsuka and Towa Conclude Basic Agreement on the Succession and Manufacturing Outsourcing of Long Listed Products, Establishing a Collaborative Framework for Stable Supply
Pharmaceuticals
DawnzeraTM (donidalorsen) granted European Union marketing authorisation for the prevention of hereditary angioedema
Pharmaceuticals
Otsuka Pharmaceutical and Dr. Keisuke Kataoka of the National Cancer Center Japan and Keio University Receive the Minister of Education, Culture, Sports, Science and Technology Award for Development of Gene Panel Test for Hematological Malignancies
Corporate
Otsuka Pharmaceutical Expands On-Site Solar Power Facilities at Factory Premises Accelerating Carbon-Neutral Initiatives
Corporate